☕️ Trial Heartbreak

CSL’s share plunge was as serious as a heart attack.

Good morning.

CSL’s chief executive Paul McKenzie will deliver the group’s December half results today, after a miserable Monday saw around $8 billion wiped of the biotech firm’s market cap. The 5.5% fall came as the company’s highly-anticipated CSL112 drug trial was deemed a failure.

CSL said the phase-three trial of CSL112, on which it spent almost $1 billion, failed to show it could reduce the risk of major cardiovascular events at 90 days after a heart attack. As a result, the company has abandoned plans to seek regulatory approval.

Head of CSL’s R&D, Bill Mezzanotte, will give an update on the CSL112 trial during today’s earnings call.

ASX as at market close. Commodities and crypto in USD.

🏆 LOI Subscriber #TBD

Market movers

Shares in casino operator SkyCity fell 2.8% during trading on Monday to close at $1.92, on news that the entertainment group has been hit with another civil penalty proceeding. NZ’s Department of Internal Affairs slapped SKC with the action, for non-compliance with anti-money laundering and terror financing laws. Earlier this month, SkyCity revised up its provision for a civil penalty from Austrac from $45 million to $73 million, after the watchdog also found "systemic failures” in SKC’s AML and CTF compliance efforts.  

The quick sync

  • Australia’s carbon trading market is shifting from a voluntary to a compliance-based system, but will this resolve its integrity issues? (Capital Brief)

  • OneVentures hits a milestone moment with the closure of its first fund, securing a payday for its backers. (AFR)

  • Calix claims it has perfected its ‘green iron’ recipe, and claims it only comes at a slight premium to traditional fossil fuel peers. (Capital Brief)

  • UBS bankers have reportedly been leading talks with PE funds for the potential buyout of languishing APM Human Services International. (AFR)

  • Administrators reveal how much Australian FTX creditors are set to scrape back after the major crypto collapse. (The Australian)

  • Cost blowout from WA’s GST deal could reach $50b in the next decade. (AFR)

  • Shares in the luxury footwear maker, Tod’s, soared 18% during trading on Monday on news that it would team up with the LVMH-backed L Catterton on a take-private bid. (Bloomberg)

  • Bosses and top execs at large US PE groups have seen the value of their shares rise by over US$40 billion since the beginning of 2023. (Financial Times)

Trading floor


  • Beach Energy CEO delays asset acquisition plans. (The Australian)

  • Diamondback Energy and Endeavor Energy are in talks for a US$50b+ ($76.7b) merger. (Capital Brief)

  • Fifth anniversary of private equity ownership prompts exit strategy discussions, citing Trade Me example. (AFR)

  • Ecofibre sells food unit to Elixinol for up to $3m. (BNA)

  • Firms eye Panoramic Resources' Savannah project once nickel prices recover. (The Australian)

  • Dispute with former owners complicates Rich Lister's Pact takeover. (AFR)

  • UK High Court approves Link Group’s fund repayment plan for Woodford creditors. (Capital Brief)

  • Starbucks Australia's CEO is optimistic about the coffee chain's future, anticipating renewed focus and investment from its owner, billionaire Russell Withers. (SMH)

  • Prime Financial Group has expanded its portfolio with the acquisition of Brisbane-based alternative asset manager Altor Capital. (BNA)

Capital Markets

  • Audinate market cap rises $266m on record sales, powered by Dante tech. (BNA)

  • Synlait eyes discounted equity raise after projected loss. (The Australian)

  • Private equity eyes ASX division carve-outs post-ski season, according to legal experts at Allens. (AFR)

  • Australian shareholders of Fletcher Building are seeking explanations for the company's trading halt on the NZX before a suspension on the local market. (The Australian)


  • Health insurer Bupa has initiated a $20m VC fund named Bupa Ventures, aimed at supporting Australian healthcare startups. (Startup Daily)

People moves

  • General Atlantic boosts Australian presence with KKR hire. (AFR)

  • Grok Ventures names former MaqBank exec Tan Kueh as CEO in a climate-focused strategy shift. (Startup Daily)

  • Bugcrowd secures $102m for global expansion in cybersecurity. (Smart Company)

  • TPG's Joel Thickins relocates to Sydney, maintains Melbourne ties. (AFR)

☝️ Know about a deal or people move we don’t? Hit reply.

Together with Wilsons Advisory

At Wilsons Advisory, our purpose is to protect, manage and grow the wealth of our private clients, including HNWs, super funds, family offices and not-for-profits with over 125 years of distinguished history in financial services.

To discuss tailored investment advice for individuals, SMSFs and trusts, please get in touch with Gagan Johal, Investment Advisor in Private Wealth, at [email protected], call +61 7 3212 1951, or click here to schedule a call.

The watercooler

If you like LOI, try The Edition

The Edition is a free afternoon newsletter that goes beneath the surface of the biggest stories in Australian business.